Endometriosis Associated Conditions

Pulmonary endometriosis in a patient with unicornuate uterus and noncommunicating rudimentary horn

Matalliotakis IM, Goumenou AG, Koumantakis GE, Neonaki MA, Koumantakis EE, Arici A

Published July 4, 2002 Fertility and Sterility, 78(1), 183-185
DOI 10.1016/s0015-0282(02)03188-6 PMID 12095511

RRM Academy Synopsis

Pulmonary endometriosis found in one woman with a unicornuate uterus

A woman who coughed up blood during each period was diagnosed with pulmonary endometriosis. This 2002 case report describes a 29-year-old with a unicornuate uterus and a noncommunicating rudimentary horn. Her chest symptoms came back after hormone treatment stopped. They did not recur during the 3 years after surgeons removed the horn.

Key Findings

  • The woman, aged 29, had recurrent cough, chest pain and hemoptysis for 6 months, and a 6-year history of secondary infertility.
  • Laparoscopy showed stage III endometriosis of the right ovary and cul-de-sac, a left unicornuate uterus and a right rudimentary horn.
  • Chest MRI on the 4th day of menstruation showed a consolidation on the right side suggesting bleeding. Bronchoscopy during menses was negative.
  • A 6-month GnRH agonist course ended her periods and chest symptoms. Hemoptysis returned 6 months after she stopped. During a second 6-month course, no further hemoptysis occurred.
  • She became pregnant 4 months after stopping GnRH treatment and delivered by cesarean section at 34 weeks. Surgeons removed the horn then, and she stayed asymptomatic for 3 years.

Interpretation

The paper is a single case report from a university hospital. The authors reviewed the world literature. They state that this is the first reported case pairing pulmonary endometriosis with a unicornuate uterus and a noncommunicating rudimentary horn. Earlier reports number 33 cases of catamenial hemoptysis, all attributed to pulmonary endometriosis. The authors write that it is unclear what resolved her chest symptoms: horn removal, a second GnRH agonist course or pregnancy.

RRM Context

Restorative reproductive medicine begins with the cycle. Here the cycle gave the clue: over 5 months, she had hemoptysis during every menses. Her symptoms returned when periods resumed after hormone suppression. They stayed absent after surgery removed the rudimentary horn, which held endometrial glands and stroma. Charted symptom timing helps clinicians find the cause.

Abstract

Objective

To report a rare case of a patient with catamenial hemoptysis, secondary infertility, and endometriosis associated with a unicornuate uterus and noncommunicating rudimentary horn.

Design

Case report.

Setting

University hospital.

Patients

A 29-year-old woman who developed progressive catamenial hemoptysis and secondary infertility was evaluated at the University Hospital of Crete.

Interventions

The complete history, laboratory data, laparoscopic findings, and chest magnetic resonance image of this patient were analyzed. A GnRH agonist, leuprolide acetate, was successfully administered.

Main Outcome Measures

Diagnosis and appropriate treatment of pulmonary endometriosis in a patient with rudimentary uterine horn.

Results

Treatment with a GnRH agonist achieved suppression of both menstruation and hemoptysis. After 6 months of normal menstrual activity, the symptoms reappeared. The patient was again treated with leuprolide acetate (3.75 mg/mo IM) for 6 months and remained asymptomatic. In fact, the patient became pregnant after cessation of therapy. Finally, the patient was treated successfully with removal of the rudimentary uterine horn during cesarean section. Three-year follow-up showed disappearance of the chest symptoms.

Conclusions

Pulmonary endometriosis and unicornuate uteri are rare. To our knowledge, this is the first case of catamenial hemoptysis with a congenital müllerian anomaly. We describe successful management using a combination of GnRH agonist and surgical resection of the rudimentary uterine horn.

Read the guide

Topics

By this author

Related research

Endometriosis › Associated Conditions › Extrapelvic Endometriosis · Therapeutics › Hormonal Agents › Gonadotropins
Ioannis M Matalliotakis, Anastasia G Goumenou, Georgios E Koumantakis, Maria A Neonaki, Eugenio E Koumantakis, Aydin Arici
I Matalliotakis, A Goumenou, G Koumantakis, M Neonaki, E Koumantakis, A Arici
PMID 12095511 12095511 DOI 10.1016/s0015-0282(02)03188-6 10.1016/s0015-0282(02)03188-6 Matalliotakis et al. 2002, Matalliotakis 2002